reports
Deepak Nitrite Ltd: 1 director
A director at Deepak Nitrite Ltd sold 950 shares at 3,052.560INR and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clea...
- Swarnendu Bhushan
MOSL: DEEPAK NITRITE: Margin pressure persists in a volatile inflation...
. DEEPAK NITRITE: Margin pressure persists in a volatile inflationary environment (DN IN, Mkt Cap USD3.4b, CMP INR1964, TP INR1887, 4% Downside, Neutral) DN reported a miss on our estimates. EBITDA came in 12% lower than our estimate at INR3.6b. EBITDA margin, at 17.3%, was also below our estimate of 20.5% – the lowest since 3QFY19. The miss was largely led by the Advanced Intermediates segment. EBIT margin declined to 18% in the Advanced Intermediates segment. The operations of the grou...
An unfavourable environment weighs on DEEPAK NITRITE, which sees a dow...
The independent financial analyst theScreener just requalified the general evaluation of DEEPAK NITRITE (IN), active in the Commodity Chemicals industry. As regards its fundamental valuation, the title still shows 0 out of 4 stars and its market behaviour is seen as moderately risky. theScreener believes that the unfavourable environment weighs on the sector and penalises the company, which sees a downgrade to its general evaluation to Slightly Negative. As of the analysis date February 1, 2022,...
- Swarnendu Bhushan
MOSL: DEEPAK NITRITE (Downgrade to Neutral)-Margin normalization at th...
DEEPAK NITRITE: Margin normalization at the cost of near term earnings growth (DN IN, Mkt Cap USD4.4b, CMP INR2429, TP INR2300, 5% Downside, Downgrade to Neutral) DN reported a mixed bag result, with EBITDA 10% higher than our estimate at INR3.9b, while EBITDA margin was lower at 23% (est. 26.7%) – the lowest since 4QFY19. Phenolics continue to act as a drag on performance of other segments, as the EBIT margin in Fine and Specialty Chemicals dip for the fourth consecutive quarter and the ...
- Swarnendu Bhushan
MOSL: DEEPAK NITRITE (Buy) - Focus on advance/high-value products inte...
DEEPAK NITRITE: Focus on advance/high-value products intensifies (DN IN, Mkt Cap USD3.7b, CMP INR2039, TP INR2350, 15% Upside, Buy) Deepak Nitrite (DN) reported a beat on our estimates, driven by better-than-expected margins in Phenolics and margins expansion in Basic Chemicals. The EBIT margin for the Fine & Specialty and Performance Products segments contracted. Despite the huge beat on our estimate, we continue to highlight the risk of overall margin contraction from the normalization...
Ford Equity International Rating and Forecast Report
Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.